Emerging Approaches in Crohn's Disease

CHF 51.55
Auf Lager
SKU
55BTCEIRHAJ
Stock 1 Verfügbar
Geliefert zwischen Di., 03.03.2026 und Mi., 04.03.2026

Details

The prevalence of Crohn's disease (CD), a chronic and life-threatening inflammatory bowel disease (IBD), is steadily increasing worldwide. A shift to personalized medicine is required because CD is a very heterogeneous disease that poses ongoing challenges in prognosis and treatment selection. The crucial and quickly developing field of disease prognosis receives a significant amount of attention. In addition to examining markers for predicting disease course and the growing potential of proteomics for forecasting disease activity and treatment response, the book goes beyond conventional evaluations to emphasize the clinical significance of biomarkers in CD. Finally, the book offers an exhaustive review of potential factors associated with the progression of CD and the current medical treatments guiding toward effective, personalized patient management.

Autorentext

Dalia Medhat, professor of medical biochemistry at the National Research Centre-Egypt, is an expert in medical research and translational science. Her work spans cancer biology, stem cell therapy, nanomedicine, and using natural compounds to treat diabetes, neurodegenerative diseases, and liver disorders.


Klappentext

The prevalence of Crohn's disease (CD), a chronic and life-threatening inflammatory bowel disease (IBD), is steadily increasing worldwide. A shift to personalized medicine is required because CD is a very heterogeneous disease that poses ongoing challenges in prognosis and treatment selection. The crucial and quickly developing field of disease prognosis receives a significant amount of attention. In addition to examining markers for predicting disease course and the growing potential of proteomics for forecasting disease activity and treatment response, the book goes beyond conventional evaluations to emphasize the clinical significance of biomarkers in CD. Finally, the book offers an exhaustive review of potential factors associated with the progression of CD and the current medical treatments guiding toward effective, personalized patient management.

Weitere Informationen

  • Allgemeine Informationen
    • GTIN 09786209048579
    • Sprache Englisch
    • Genre Biology
    • Größe H220mm x B150mm
    • Jahr 2025
    • EAN 9786209048579
    • Format Kartonierter Einband
    • ISBN 978-620-9-04857-9
    • Titel Emerging Approaches in Crohn's Disease
    • Autor Dalia Medhat
    • Untertitel Crohn's Disease: Pathogenesis and Prognostic Biomarkers with Precision Therapeutics.DE
    • Herausgeber LAP LAMBERT Academic Publishing
    • Anzahl Seiten 80

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470
Kundenservice: customerservice@avento.shop | Tel: +41 44 248 38 38